BNP Paribas SA vs Vertex Pharmaceuticals Incorporated
Market cap comparison over time
BNP Paribas SA
$109.2B
Rank #143
Vertex Pharmaceuticals Incorporated
$113.0B
Rank #141
Market Cap Over Time
Key Moments
- Vertex Pharmaceuticals Incorporated overtook BNP Paribas SA by 1996
- BNP Paribas SA overtook Vertex Pharmaceuticals Incorporated by 1997
- Vertex Pharmaceuticals Incorporated overtook BNP Paribas SA by 2000
- BNP Paribas SA overtook Vertex Pharmaceuticals Incorporated by 2001
- Vertex Pharmaceuticals Incorporated overtook BNP Paribas SA by 2018
Year-by-Year Comparison
| Year | BNP Paribas SA | Vertex Pharmaceuticals Incorporated | Leader |
|---|---|---|---|
| 2026 | $109.2B | $113.0B | Vertex Pharmaceuticals Incorporated |
| 2025 | $93.2B | $115.1B | Vertex Pharmaceuticals Incorporated |
| 2024 | $62.1B | $102.2B | Vertex Pharmaceuticals Incorporated |
| 2023 | $61.5B | $103.3B | Vertex Pharmaceuticals Incorporated |
| 2022 | $48.9B | $73.3B | Vertex Pharmaceuticals Incorporated |
| 2021 | $52.0B | $55.7B | Vertex Pharmaceuticals Incorporated |
| 2020 | $35.2B | $60.0B | Vertex Pharmaceuticals Incorporated |
| 2019 | $43.1B | $55.6B | Vertex Pharmaceuticals Incorporated |
| 2018 | $30.0B | $42.1B | Vertex Pharmaceuticals Incorporated |
| 2017 | $44.8B | $38.0B | BNP Paribas SA |
| 2016 | $41.8B | $18.7B | BNP Paribas SA |
| 2015 | $34.4B | $31.9B | BNP Paribas SA |
| 2014 | $31.6B | $30.2B | BNP Paribas SA |
| 2013 | $35.3B | $18.9B | BNP Paribas SA |
| 2012 | $25.7B | $10.6B | BNP Paribas SA |
| 2011 | $17.4B | $8.4B | BNP Paribas SA |
| 2010 | $26.3B | $8.9B | BNP Paribas SA |
| 2009 | $30.0B | $10.9B | BNP Paribas SA |
| 2008 | $15.9B | $7.7B | BNP Paribas SA |
| 2007 | $37.0B | $5.9B | BNP Paribas SA |
| 2006 | $39.4B | $9.5B | BNP Paribas SA |
| 2005 | $30.0B | $7.0B | BNP Paribas SA |
| 2004 | $21.7B | $2.7B | BNP Paribas SA |
| 2003 | $19.5B | $2.6B | BNP Paribas SA |
| 2002 | $14.2B | $4.0B | BNP Paribas SA |
| 2001 | $17.6B | $6.2B | BNP Paribas SA |
| 2000 | $16.0B | $18.1B | Vertex Pharmaceuticals Incorporated |
| 1999 | $15.4B | $4.4B | BNP Paribas SA |
| 1998 | $11.6B | $3.8B | BNP Paribas SA |
| 1997 | $7.3B | $4.2B | BNP Paribas SA |
| 1996 | $3.9B | $5.1B | Vertex Pharmaceuticals Incorporated |
| 1995 | $3.8B | $3.4B | BNP Paribas SA |
| 1994 | $3.8B | $1.9B | BNP Paribas SA |